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The Use of Electronic Maternal Early Warning Criteria to Improve Treatment of Hypertension in 
Hospitalized Obstetric Patients 
Abstract 
Background: It is difficult to recognize that an obstetric patient’s condition is deteriorating 
because normal physiological changes in pregnancy generate significant shifts in maternal vital 
signs.  Elevated blood pressures can be treated to prevent clinical deterioration. Electronic 
maternal early warning criteria (EMEWC) were set for severe range blood pressure parameters 
for a systolic blood pressure of 160 mm Hg and a diastolic blood pressure of 110 mm Hg in a 
cohort of inpatient obstetric patients diagnosed with hypertension.  
Objective: Increase the rate of antihypertensive medication administration within one hour of 
the severe range blood pressure.   
Methods:  Severe range blood pressure parameters were set in the Cerner® FetaLinkTM software 
and provided audible and visual alerts to nurses when the patient’s condition deteriorated. 
Prompt recognition of the abnormal findings were evaluated by the timing of the administration 
of an antihypertensive medication.   
Results: A total of 103 obstetric patients met study criteria. Pre-intervention, 15.5% of obstetric 
patients were treated with an antihypertensive medication within one hour of a severe range 
blood pressure. Post-intervention, the rate of treatment increased to 21.9%, although not 
significant (p = .42).  
Conclusions: The use of EMEWC can assist with improving the recognition of clinical 
deterioration and prompt care interventions. Lessons learned from this quality improvement 
project can be applied to improving outcomes with other pregnancy complications. 
 
UTILIZING MATERNAL EARLY WARNING CRITERIA 4 
 
Key Words: maternal early warning, electronic early warning systems, maternal clinical 
deterioration 
UTILIZING MATERNAL EARLY WARNING CRITERIA 5 
 
Acknowledgements 
I would like to first thank my husband, Jeff Bowers, and two sons, Ben and Will, for their 
unconditional support and family adjustments while pursing my educational goals over the last 
two years.  The meals, extra car pool routes and prayers from my family, friends, and neighbors 
helped our family through tough days. My hospital peers offered me guidance to navigate 
hurdles and challenged me to advocate for quality improvement tools for the obstetric service 
line. I want to thank my project committee, chair Dr. Debra Kosko and Dr. Angie Hatley, for 
their continued guidance throughout the project. A dear friend, Dr. Julie Thompson, has been 
gracious to tutor me through several courses and double check the statistical data for this 
scholarly project. This project was a total group effort! 
 
UTILIZING MATERNAL EARLY WARNING CRITERIA 6 
 
Table of Contents 
Chapter I: Introduction         
 Introduction to the Problem         8 
 Background of Problem         9 
 Significance of the Problem        10  
` Purpose with Aims and Objectives       12 
 Practice Setting Support        13 
 Project Hypothesis         14  
 Assumptions          15 
 Definition of Terms         15 
 Summary          17 
Chapter II: Research Based Evidence 
 Introduction          18 
 Critical Analysis of Literature       18 
 Synthesis of Evidence         30 
 Gap in Literature         31 
 Evidence Based Model        32 
 Theoretical Framework         32 
 Summary          33 
Chapter III: Methodology 
 Needs Assessment         35 
 Project Design         35 
 Future Plans          40 
 Estimated Resources and Costs       41 
Chapter IV: Results           
 Sample Characteristics        42 
 Major Findings         43 
UTILIZING MATERNAL EARLY WARNING CRITERIA 7 
 
Chapter V: Discussion          
 Project Results Relation to Theoretical Framework      45 
 Significance of Results to HealthCare       46 
 Project Strengths and Limitations        48 
 Benefit of Project to Practice         50 
 Recommendations for Practice        51 
References            53 
Appendices 
 Appendix A:  Hospital Letter of Support       61 
 Appendix B: Carolinas HealthCare System NSAC Approval    62 
 Appendix C: Carolinas HealthCare System IRB Determination    63 
 Appendix D: East Carolina University IRB Determination     67 0 
 Appendix E:  DNP Scholarly Project Time Line      68 
 Appendix F: Maternal Early Warning Criteria Parameters     69 
 Appendix G:  Literature Evidence Table                    70 
 Appendix H:  Iowa Model of Evidenced Based Practice                 84 
 Appendix I:  Cerner® FetaLinkTM Web-Based Training     85 
 Appendix J:  Cerner® FetaLinkTM Blood Pressure Notifications    91 
 Appendix K:  Treatment Outcomes for Severe Range Blood Pressures                    93 
            Appendix L:  DNP Essential Competency and Demonstration Method   94 
  
UTILIZING MATERNAL EARLY WARNING CRITERIA 8 
 
The Use of Electronic Maternal Early Warning Criteria to Improve Treatment of Hypertension in 
Hospitalized Obstetric Patients 
Chapter I: Introduction 
Introduction to the Problem 
Maternal mortality is infrequent in the United States, but when it occurs, has a 
devastating effect on both families and hospital staff. Although the World Health Organization 
(2015) announced a 44% reduction in worldwide maternal mortality since 1990, opportunity 
remains for improving obstetric health outcomes within our nation. Maternal deaths are 
attributed to delays in recognition, diagnosis, and treatment of patients’ experiencing signs of 
clinical deterioration (Cantwell et al., 2011).  Obstetric patients could benefit from the use of 
early warning systems that scan the electronic health record (EHR) for abnormal vital signs.  
The Healthy People 2020 target goal of reducing the rate of maternal mortality from 12.7 
to 11.4 maternal deaths per 100,000 live births is lofty, but achievable (Maternal, Infant, and 
Child Health, 2016). The Centers for Disease Control and Disease Prevention (CDC) (2016a) 
reports approximately 600 women die annually in the United States because of complications 
with their pregnancy or delivery. To assist in further reducing the maternal mortality rate, 
hospitals will need to evaluate their inpatient data on maternal illness and pregnancy 
complications.  The CDC monitors maternal deaths in the United States through their pregnancy 
mortality surveillance system. In 2012, the pregnancy-related mortality ratio was 15.9 deaths per 
100,000 live births with 7.6% of deaths caused by hypertensive disorders of pregnancy (Centers 
for Disease Control and Disease Prevention [CDC], 2016b). In-depth maternal death case 
reviews have identified diagnostic trends that include cardiovascular disease, pregnancy related 
hypertension disorders, hemorrhages, pulmonary and amniotic fluid embolisms, and infection 
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(Berg, C., Callaghan, W., Syverson, C. & Henderson, Z., 2010; CDC, 2016a). The search needs 
to continue to address the most common preventable cause of maternal deaths. 
Background of the Problem 
 It is difficult to recognize that an obstetric patient’s condition is deteriorating because 
normal physiological changes in pregnancy generate significant shifts in maternal vital signs. 
One of the major physiological changes that occurs during pregnancy occurs during the second 
trimester; The cardiovascular system is affected as blood volume doubles while systemic 
vascular resistance decreases. In turn, blood pressure drops and can cause dizziness or fainting. 
By the third trimester, blood pressure usually returns to pre-pregnancy ranges, but an abnormal 
rise during this time can be an indication of hypertensive disorders in pregnancy. Elevated blood 
pressures can be treated to prevent deteriorating clinical outcomes for mother and fetus. 
The American College of Obstetricians and Gynecologists (ACOG) (2013) follows a 
four-category classification system, each with its own qualifiers, to describe hypertensive 
disorders in pregnancy: chronic hypertension, gestational hypertension, preeclampsia-eclampsia, 
and chronic hypertension with superimposed preeclampsia.  The least severe hypertensive 
category, gestational hypertension, is diagnosed with the presence of a systolic blood pressure 
(sBP) 140 mm Hg or higher and/or a diastolic blood pressure (dBP) of 90 mm Hg or higher, on 
two separate measures, greater than four hours apart, before and after the 20th week of pregnancy 
(ACOG, 2013). As the categories progress in severity, preeclampsia blood pressure readings 
elevate to sBP 160 mm Hg or higher and/or dBP 110 mm Hg or higher, on two separate 
measures, greater than four hours apart, while the patient is on bed rest and include other organ 
involvement criteria (ACOG, 2013). Blood pressures meeting either of these parameters are 
referred to as severe range. Evidence suggests that treating severe range blood pressures with a 
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first line antihypertensive is needed to prevent repeated or sustained elevated blood pressure 
levels (ACOG, 2015; Clark & Hankins, 2012). 
Regardless of the presence or absence of hypertension during pregnancy, blood flow to 
the placenta can be compromised—leading to poor neonatal outcomes. The maternal organs 
affected by hypertension during pregnancy include the kidneys, liver, and brain, and new 
evidence reveals that an increased risk of future cardiovascular disease exists. Causes of 
hypertensive disorders, and, more specifically, preeclampsia, are unknown; in fact, the only 
constant apparent is the presence of a placenta. At present, the only “cure” for hypertensive 
disorders during pregnancy is delivery of the baby, end of the pregnancy, and expulsion of the 
placenta. Treatment is comprised of managing blood pressure, monitoring organ involvement, 
and determining when the delivery needs to occur for optimum well-being of both mother and 
fetus. It is important to note that transition from the hypertensive condition to a non-hypertensive 
condition does not occur immediately during the postpartum period. Most patients’ blood 
pressures decrease after the placenta is delivered, but spikes in blood pressure can occur during 
the postpartum period, and they can continue to occur for up to six weeks after delivery.  
Significance of the Problem 
Preeclampsia is a frequently and widely researched condition, as it has been recurrently 
associated with “high rates of maternal and neonatal morbidity and mortality” (Moodley, 2011, 
p. 330). Hypertensive disorders are a common medical complication that affect approximately 
10-13 % of pregnancies (Berg et al., 2010).  The California Maternal Quality Care Collaborative 
(CMQCC) (2013) has been evaluating maternal morbidity and mortality in California for just 
over a decade. Their findings revealed an emerging theme relating to lack of timely treatment: 
“despite triggers that clearly indicated a serious deterioration in the patient’s condition, health 
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care providers failed to recognize and respond to these signs in a timely manner leading to delays 
in diagnosis and treatment” (California Maternal Quality Care Collaborative [CMQCC], 2013, p. 
5). The American Heart Association joined with the American Stroke Association in recognizing 
urgency for, and importance in, future research for the prevention of stokes in women 
specifically because links have been identified between pregnancy and preeclampsia as gender-
specific risk factors for future disease (Bushnell et al., 2014). Since high blood pressures in 
pregnancy present dangers for both the mother and the fetus, health care professionals must stay 
vigilant within their efforts to recognize and treat hypertension during pregnancy in a timely 
manner.  
The project facility is a regional 457-bed, not-for-profit medical center located in the 
southern piedmont region of North Carolina. Statistics for hypertension in pregnancy rates at this 
facility parallel those found in field literature. Approximately 10% of obstetric patients are coded 
with a hypertensive diagnosis, and, of those, 40% are hospitalized to control their blood 
pressures and the progression of the disease. For the purposes of this project, severe range blood 
pressure is defined as an elevated sBP of 160 mm Hg or higher and/or dBP of 110 mm Hg or 
higher on two separate readings greater than 15 minutes apart.  
The project facility’s rate of administration of an antihypertensive medication within an 
hour of a severe range blood pressure is 15.5% for the first nine months of the project year. 
Although no national benchmark exists, the healthcare system participates in the prestigious 
national Partnership for Patients Healthcare Engagement Network (HEN). The HEN goals for 
administering an antihypertensive medication within one hour of a severe range blood pressure 
for hypertensive patients have been set at 56% target and 65% stretch. During the HEN, focused 
improvements to assist with administering an antihypertensive within one hour of recognition 
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include standardizing blood pressure measurement education, building provider shared baseline 
protocols for antihypertensive medications, and placing medications on override in the 
medication dispensing systems to avoid a delay while awaiting pharmacy verification. There is 
no question that this disease needs a multifaceted approach to management, but recognizing 
signs of clinical deterioration, and notifying providers of these signs, specifically the presence of 
a severe range blood pressure, is a process measure that nurses can and should be responsible to.    
Purpose with Aims and Objectives 
Though there is evidence to support the use of computerized early warning systems in 
hospital settings, there is limited data on their use in hospitalized obstetric patients. The literature 
reveals there is not a specific validated instrument to detect a patient’s clinical deterioration that 
can be built into the EHR; yet, research does identify detailed objective clinical signs that present 
prior to a patient’s clinical deterioration. Within my research and subsequently, within this 
project, I propose implementing the use of electronic maternal early warning criteria (EMEWC) 
to evaluate the obstetric patient’s clinical picture, and to alert nursing staff of the necessity for a 
bedside evaluation, in the event of abnormal parameters. The guiding Population/Problem-
Intervention-Comparison-Outcome (PICO) question is: In hospitalized obstetric patients with a 
hypertensive diagnosis (P), will the use of the EMEWC (I), measured pre-and post-
implementation (C), increase the rate of an antihypertensive medication administered within one 
hour of a patient’s severe range blood pressure occurrence (O)? The purpose of this quality 
improvement project is to determine if the use of the EMEWC will increase treatment of severe 
range blood pressure—within one hour of recognition—in a cohort of hypertensive obstetric 
patients hospitalized in labor and delivery (L&D) and high risk obstetric (HROB) units. The 
long-term outcome measure for this Doctorate in Nursing Practice (DNP) scholarly project is to 
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examine if/whether early recognition and treatment of severe range blood pressures improve 
rates of treatment for severe range hypertensive crisis.    
Practice Setting Support 
Reducing mortality rates is a constant patient safety goal for the hospital, as well as its 13 
sister facilities within the healthcare system that offer obstetric services. Recently, a sepsis 
warning system was implemented for inpatients outside of the obstetric setting, and favorable 
results ensued as evidenced by a decreased mortality rate. Due to the positive outcomes of the 
sepsis program, the hospital supports the evaluation and implementation of an electronic tool to 
assist with recognizing clinical deterioration in other service lines including those of obstetric, 
neonatal, and pediatric populations. The hospital’s Assistant Vice President of Nursing Practice 
and the hospitals system’s Chief Nursing Informatics Officer were approached regarding the 
need to incorporate the obstetric service line into quality initiatives that were being implemented. 
Both individuals offered support for this project to move forward including contacting our 
electronic health record (EHR) vendor, Cerner®, to see if they already had a program available 
for adoption.  
As of the time of this writing, Cerner® does not have any programs available, but several 
other hospitals have also inquired about implementing maternal early warning systems, and they 
requested for the facility to participate in the product build. The project facility offered support 
through allowing distribution of the clinical nurse specialist workload to accommodate the 
evidence based project (Appendix A). The information systems department at the healthcare 
system level will assist with building and installing the electronic maternal early warning criteria 
through a program called Cerner® FetaLinkTM. Carolinas HealthCare System has two governing 
bodies that guide nursing evidence based projects. The Nursing Scientific Advisory Council 
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(NSAC) reviewed the proposal and offered approval to proceed with implementing the project 
(Appendix B). The Carolinas HealthCare System Institutional Research Board (IRB) deemed this 
project as Quality Improvement (Appendix C).  East Carolina University’s Institution Review 
Board deemed the project as quality improvement and not human subject research, so no further 
review was required (Appendix D). The overall time line (Appendix E) for this project spanned 
18 months from idea conception to project completion.  
Although there have not been any recent maternal mortality cases to prompt immediate 
action, the project facility’s Perinatal Quality Committee (PQC), which is comprised of 
physician and nursing leaders, evaluated obstetric literature for trends in clinical parameters for 
maternal early warning systems. The maternal early warning criteria (MEWC) evaluated is not 
specific to a disease such as sepsis, but the criteria include parameters that mark clinical 
deterioration for many complications. ACOG Committee Opinion Number 590 (2014) 
recommends that “each health care setting should examine its own data to determine which 
events require evaluation of the early warning system” (p.2). The PQC discussed pros and cons 
of criteria found in literature, and it endorsed a set of high and low vital sign parameters. PQC 
recommendations were subsequently submitted to the Obstetrics (OB) Department where all 
inpatient obstetric providers discussed the selected parameters. Consequently, a unanimous vote 
of acceptance for EMEWC was established (Appendix F).   
Project Hypothesis 
 EMEWC recognizes abnormal clinical parameters, and it provides an audible alarm that 
will prompt staff and providers to perform a bedside assessment of the patient. If a severe range 
blood pressure remains, nurses can initiate provider orders to prevent further clinical 
deterioration. The timely recognition of abnormal severe range blood pressures will increase the 
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rate of an antihypertensive medication administration within one hour of a severe range blood 
pressure in obstetric patients.  
Assumptions 
       The proposed DNP scholarly project has been deemed a quality improvement initiative to 
evaluate whether the use of an electronic early warning system (EWS) can improve health 
outcomes. Prior to the implementation of the electronic EWS, vital signs are entered a patient’s 
EHR in multiple ways: a nursing assistant enters the values, the current fetal heart monitoring 
program transfers them in automatically, or the nurse will enter them. A delay in recognition of 
the vital sign measurements in the past has, unfortunately, resulted in untimely patient 
interventions. Utilizing the new Cerner® FetaLinkTM program features for setting vital sign 
parameters for severe range blood pressure, along with audible and visual alerts serves as an 
EWS for detecting a patient’s clinical deterioration. Use of the electronic EWS in hospitalized 
obstetric patients should significantly improve the rate of administration of an antihypertensive 
medication within one hour of a severe range blood pressure. 
Definition of Terms 
• Cerner®- the data software company who developed and implemented the EHR utilized 
in this scholarly project. 
• Early Warning Systems- a single, multiple, or aggregate-weighted scoring tool either 
print or electronic used to identify physiological parameters and track a patient’s 
condition. Heart rate, respiratory rate, blood pressure, temperature, and oxygen level are 
common parameters monitored to assist with detecting clinical deterioration; when an 
abnormal value results, a trigger prompts appropriate intervention.  
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• Electronic Health Record- A digital version of a patient’s medical history, assessments, 
interventions, provider orders, laboratory results, medications, and test results that assist 
the healthcare team in providing a thorough longitudinal approach to care.  
• Cerner® FetaLinkTM - the Cerner® application for assessment of the fetus during 
pregnancy. The application is located at the patients’ bedside, and it transfers assessments 
of both the mother’s and fetus’s condition into the EHR. Vital sign parameters for normal 
limits can be set, and audible (audio) and visual alarms will be enacted if a patient’s 
clinical condition deteriorates outside of desired parameters. Notifications and patient 
interventions can be documented in this program to address alarms.   
• Hypertensive crisis- severe systolic hypertension (greater than, or equal to, 160 mm Hg) 
or severe diastolic hypertension (greater than, or equal to, 110 mm Hg) that persist for 15 
minutes or more. 
• Maternal Early Warning Criteria- abnormal low and high physiological parameters 
that indicate the need for urgent beside assessment by healthcare staff can escalate a 
response to care using diagnostic and therapeutic interventions.  
• Morbidity- the condition used to describe a focus of death or how often a disease occurs 
in a specific region.  
• Mortality- death of a large number of people used to describe health population trends. 
• Obstetric patient- a time describing a pregnancy which includes any gestational age of a 
pregnancy during the antepartum period and the intrapartum period, as well as the time 
from birth until the 42nd day postpartum.  
• Severe range blood pressure- elevation of a sBP to 160 mm Hg or higher and/or a dBP 
110 mm Hg or higher. 
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• Track and trigger systems- this is a process that periodically measures observations 
(track) with predetermined action when certain thresholds are reached (trigger). The 
observations tracked in this project were blood pressure parameters. The trigger was 
programmed at sBP elevations to alert staff. The electronic fetal surveillance system 
allows for facilities to set track parameters and trigger frequencies. 
• Vital Signs- physiological measurements of a patient’s essential body functions including 
pulse (heart rate), respirations (respiratory rate), blood pressure, and temperature.  
Summary 
 Hypertensive disorders complicate up to 10% of pregnancies, and they are a leading 
cause of maternal and perinatal morbidity and mortality worldwide. Preeclampsia, a subset of the 
hypertensive disorders, has increased by 25% in the United States during the past two decades; 
consequently, it is a risk factor for future cardiovascular disease and metabolic disease in 
women. Local hospital system data shows approximately 20% of patients are coded with a 
hypertensive disorder during pregnancy, and, of those, approximately 15% of patients experience 
an episode of severe range blood pressures. The recommended treatment to prevent long term 
complications is administration of an antihypertensive medication within one hour of the onset of 
a severe range blood pressure.  The EMWEC will assist the staff with early recognition of signs 
of patient’s clinical deterioration.  
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Chapter II: Researched Based Evidence 
Introduction 
 Within the literature review, supporting evidence is divided into sections based on 
separate and distinctive themes. A literature search was performed utilizing CINAHL Complete, 
PubMed, and Nursing and Allied Health databases. Key terms included maternal early warning, 
electronic early warning systems, maternal clinical deterioration, maternal morbidity, and 
maternal mortality.  Limitations within the scope of my search included literature published no 
earlier than the last 10 years, literature published in the English language, and that which utilized 
human subjects within their research in order to incorporate landmark studies and 
recommendations on the subject matter. In addition, I included a search for gray literature from 
professional organizations and national committees within my search. The following section 
outlines supporting literature in detail, while Appendix G offers highlights of current evidence 
related to the development of an electronic EWS to be subsequently implemented within this 
quality improvement project.   
Critical Analysis of Literature 
 Hypertension in Pregnancy. Clark et al. (2008) performed a retrospective maternal 
death case review in order to examine trends in causes, prevention, and specific relationships 
with cesarean deliveries. They found that, of 17 deaths considered to be preventable, five cases 
involved the preeclampsia diagnosis.  The authors determined that the “most preventable errors 
in preeclampsia management leading to maternal death involved inattention to blood pressure 
control and signs or symptoms of pulmonary edema” (Clark et al., 2008, p, 36e4).  
 Blood Pressure Control. Clark and Hankins (2012) researched recurrent errors that 
account for maternal deaths, and they offered 10 “clinical diamonds” that address key principles 
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to help reduce the possibility of errors in care that can lead to maternal mortality. One “diamond” 
centers around untreated blood pressures which often precede events of clinical deterioration. 
“Any hospitalized patient with preeclampsia experiencing either sBP of 160 mm Hg, or a dBP of 
110, should receive an intravenous antihypertensive agent within 15 minutes” (Clark & Hankins, 
2012, p. 361). The authors recommend this single dose will not harm a patient, and they propose 
this should be an automatic response. The timing outlined in the article suggested a 15-minute 
window from recognition of elevated blood pressures to administration of the antihypertensive 
agent which is an aggressive administrative timeframe. 
 ACOG (2015a) presented a collective opinion on emergent therapy for the acute-onset, 
severe hypertension during both pregnancy and postpartum periods to aid in reducing adverse 
maternal outcomes. “Individuals and institutions should have mechanisms in place to initiate the 
prompt administration of medication when a patient presents with a hypertensive emergency” 
(ACOG, 2015a, p. 1). Central nervous system injury can occur at these parameters of elevated 
blood pressures. In the event of the hypertensive emergency, first-line therapy is recommended 
with an antihypertensive to prevent repeated or sustained elevated blood pressure levels. 
Safety Measures. Many clinical emergencies are preceded by a period of instability in a 
patient’s condition; therefore, timely assessment and intervention are key to the improvement of 
clinical outcomes. ACOG Committee Opinion Number 590 (2014) encourages hospitals, 
specifically obstetric and gynecologic units, to prepare for clinical emergencies by recognizing 
changes in patients’ conditions that require immediate intervention. The Joint Commission (TJC) 
(2010) issued sentinel event alert #44 to assist with preventing maternal deaths. A suggested 
action for hospitals included “identify[ing] specific triggers for responding to changes in the 
mother’s vital signs and clinical condition and [to] develop and use protocols and drills for 
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responding to changes” (The Joint Commission [TJC], 2010, p.3). Obstetric patients with 
comorbid conditions, such as hypertension, could benefit from the use of early warning systems 
that scan the electronic health record (EHR) looking for abnormal vital signs and deteriorating 
conditions. 
The Joint Commission’s Provision of Care, Treatment and Services chapter (2016) has a 
standard, PC.02.01.19, for each hospital to utilize an outlined process to recognize and respond 
to a patient’s deteriorating condition. The supporting rationale stems from evaluation of a vast 
number of critical inpatient events that were preceded by changes in the patient’s condition. 
Furthermore, hospitals standards require, in writing, early warning signs of clinical deterioration 
be determined and that a specific plan be in place for staff to call for assistance. Prior to this 
edition of standards, TJC (2010) issued a sentinel event alert #44 to assist with preventing 
maternal deaths. A suggested action for hospitals was to “identify specific triggers for 
responding to changes in the mother’s vital signs and clinical condition and develop and use 
protocols and drills or responding to changes” (TJC, 2010, p. 3). 
Clinical Deterioration Recognition. Cantwell et al. (2011) report that new staff, of all 
levels, lack the clinical knowledge and skills needed to recognize signs of deterioration. This 
position is evidenced by healthcare providers failing to distinguish the signs and symptoms of 
certain pregnancy conditions and others who failed to identify when a female was becoming 
seriously ill. When the early warning signs of clinical deterioration are unrecognized in routine 
patients, it remains a challenge to implement early detection with severe illness especially in 
obstetric patients where physiological adaptions have occurred (Cantwell et al., 2011). The case 
reviews of maternal deaths in this expert consensus report revealed early warning signs of 
impeding maternal collapse went unrecognized.  
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Lawton et al. (2010) performed a descriptive study of 29 charts of women who were 
admitted to an intensive care unit (ICU) who were coded to have a severe acute maternal 
morbidity. Ten percent of these cases were deemed preventable, and themes were identified that 
lead to poor patient outcomes which include inadequate diagnosis/recognition of high-risk status, 
inappropriate treatment, communication problems, and inadequate documentation. Although the 
number of patients monitored was small, and this study was conducted at a single site, the results 
can be utilized by other obstetric facilities to hone processes around these preventable events to 
improve the recognition of clinical deterioration.  
After performing retrospective chart audits on 65 ICU admissions, Jonsson, Jonsdottir, 
Moller, and Baldursdottir (2011) found that an increased respiratory rate was the most common 
precursor to clinical deterioration. The study measured documentation of vital signs prior to 
clinical deterioration and subsequent transfer of a patient into the ICU, and it found that the 
respiratory rate was also the most poorly documented parameter. The authors urge nurses to be 
alert to the necessity of documenting early signs of deterioration of patients including, 
specifically, those pertaining to vital signs.  
Early Warning Systems (EWS). The United Kingdom has led industrialized countries 
in promoting initiatives to decrease maternal mortality. The Confidential Enquiries into Maternal 
and Child Health (CEMACH) is an interprofessional team that meets every three years to review 
nations’ maternal morbidity and mortality trends and to make recommendations, known as 
“Saving Mothers’ Lives” reports, for practice. CEMACH’s review of the trends from 2003-2005 
culminated in the recommendation of the use an obstetric early warning system.  
Swanton, Al-Rawi and Wee (2009) reported on the United Kingdom’s efforts to develop 
a universally valid EWS that accommodates the obstetric patients’ physiological changes during 
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pregnancy. A mail survey to members of the Obstetric Anesthetists’ Association was conducted 
to ask for opinions on the value of an obstetric early warning system as well as how one could be 
implemented. Of the 71% of respondents, 89% thought it would be possible to implement an 
obstetric EWS if it was simple, “universal, validated, and relevant to obstetric physiology and 
disease” (Swanton, Al-Rawi & Wee, 2009 p. 254). Of note, 19% (30 hospital units) reported 
using various forms of an obstetric EWS (Swanton et al., 2009). Using these responses, the 
authors could develop a paper draft of an obstetric early warning tool, and they distributed it for 
validation. Swanton et al.’s (2009) persistence led to the alteration of the EWS triggers from 
adult services to incorporate the physiological parameters of pregnancy. The resulting Modified 
Early Obstetric Warning System (MEOWS) would develop into a paper, color coded tool 
designed to detect early signs of clinical deterioration through monitoring vital signs. The 
MEOWS soon became a useful tool, and, although it had not yet been validated, subsequently 
gained widespread acceptance.   
The adoption of the use of an EWS gained momentum within a just few short years. Five 
years after evaluating the anesthetists’ opinions of the implementation of an EWS, Isaacs et al. 
(2014) conducted a follow-up survey. By querying 205 lead obstetric anesthetists about the use 
of an EWS for their patients. These authors aimed to identify which EWS was currently in use 
within obstetric practice, exactly which physiological parameters were included, and authors 
asked for comments on problems associated with the EWS. With 130 completed surveys 
returned, all providers reported they used an EWS a significant numerical gain from the 19% that 
Swanton et al. (2009) originally reported. The respondents reported that MEOWS were used in 
45% of the units, a modified version was in use in 50% of the units, and a different system was 
in place within 5% of the units (Isaacs et al., 2014). Of the lead anesthetists who completed the 
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survey, 118 (91%) agreed that the obstetric morbidity rate was improving since the 
implementation of an EWS. The six physiological parameters the respondents routinely utilized 
through various versions of obstetric EWS include the following: respiratory rate, heart rate, 
temperature, and oxygen saturation along with both the systolic and diastolic blood pressures 
readings. All versions of an EWS utilized in obstetric units evaluated in this study “track” 
parameters for trends, or they use a “trigger” system where single, multiple, or aggregate-
weighted scoring systems identify the need for a patient evaluation by a provider.   
Carle, Alexander, Columb, and Johal (2013) ventured to validate an aggregate-weighted 
early warning scoring system aimed for use outside of the ICU setting. A retrospective audit of 
direct obstetric admissions to ICU’s in the United Kingdom, Wales, and Ireland was performed. 
The charts were collected from the National Audit and Research Centre (ICNARC) Case Mix 
Programme (CMP), and the authors utilized a random allocation method of assigning direct 
obstetric intensive care admissions into a development (n=2240) or validation group (n= 2200). 
The statistical and clinical early warning scores were internally validated. The area under the 
receiver operating characteristic curve was 0.995 (95% CI 0.992-0.998) for the statistical score 
and 0.957 (95% CI 0.923-0.991) for the clinical score. This aggregate-weighted score was 
compared to other empirically designed early warning scores, and results indicate that this 
clinical obstetric early warning score can distinguish between survivors from non-survivors in 
this ICU data set. The authors’ next steps would be to validate this tool outside of the ICU for 
use on ward patients.  
 Singh, McGlennan, England, and Simons (2012) set out to validate the United 
Kingdom’s recommended MEOWS tool by measuring its sensitivity, specificity, and predictive 
value. They reviewed 676 consecutive obstetric admissions, through a retrospective audit, to 
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evaluate patient’s MEOWS triggers. The MEOWS was 89% sensitive (95% CI 81–95%) 
and79% specific (95% CI 76– 82%), with a positive predictive value of 39% (95% CI 32–46%) 
and a negative predictive value of 98% (95% CI 96–99%). This study suggests that MEOWS is a 
useful bedside tool for predicting morbidity not mortality. The authors suggest further research 
should aim at evaluating adjusted trigger parameters to improve positive predictive value. 
Mackintosh, Watson, Rance, and Sandall (2014) argue that the use of the MEOWS is 
“based on intuitive appeal and no validated system for use in the maternity population currently 
exists” (p. 26). Over the course of seven months, the authors completed an ethnographic study 
using observations, interviews, and documentary reviews, within two United Kingdom hospitals, 
in order to evaluate if the MEOWS was a valuable tool for managing maternal complications in 
the antenatal and postnatal period in women who had risks of morbidity. Observation and 
interview techniques were utilized to perform an ethnographic study to further understand the 
MEOWS. They worked with doctors, midwives, and managers to evaluate the complexities of 
managing risk/s and safety costs, as well as opportunity costs, associated with the tool. Results of 
the study revealed that the establishment of set triggers assisted healthcare providers to identify 
shared meanings for maternal complications; however, the use of the MEOWS with patients with 
low morbidity risks may not prove to be effective. They also call into question its role for routine 
use versus use solely for individuals with an established risk of morbidity. 
The United Kingdom’s recommendation/s for routine use of an EWS in obstetric patients 
began to spread to other regions as a testament to the improved maternal morbidity and mortality 
rates. Incidentally, the Australian and New Zealand obstetrics and gynecology community 
sought to perform their own studies. Austin et al. (2014) sought to determine whether the use of 
an EWS on a tertiary care maternity unit will improve the detection of severe maternal 
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morbidity, or lessen the severity of illness, among women with severe morbidity. The use of the 
tool may have reduced the seriousness of maternal morbidity within five cases. It was 
specifically noted that no patients had a complete set of respiratory rate, heart rate, blood 
pressure and temperature recordings at every time period.  
In the United States, Mhyre et al. (2014) proposed, through the works of the National 
Partnership for Maternal Safety, that Maternal Early Warning Criteria (MEWC) would facilitate 
timely recognition, diagnosis, and treatment for patients exhibiting clinical deterioration. The 
suggested MEWC were extracted as the upper and lower boundary parameters, or “red” 
triggers”, outlined in the MEOWS presented by Singh et al. in 2012. The group evaluated 
records and results that trended in favor of a single-parameter risk assessment system that would 
offer simplicity and specificity. This system would also limit the multi-level scoring systems that 
“rely on nurses to document, calculate, and interpret the scores” (Mhyre et al., 2014, p. 783). The 
authors recognized that randomized control trials will be needed to validate the parameters of 
their suggested single parameter MEWC.  
In India, the MEOWS chart emerged as a useful bedside tool for predicting maternal 
morbidity, and the authors support its routine use (Singh, Guleria, Vaid, & Jain, 2016). As 
mentioned in earlier studies, the MEOWS uses a “track and trigger” system to monitor 
physiological parameters which aid in recognition of clinical deterioration at an early stage, 
ultimately halting clinical deterioration and suffering maternal morbidity and mortality. 
Incidentally, the MEOWS chart was 86.4% sensitive, 85.2% specificity, 53.8% positive 
predictability, and 96.9% negative predictability. Parameters also had a significant correlation 
(p<0.05) with obstetric morbidity.   
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Hedriana, Weisner, Downs, Pelletreau, and Shields (2015) had an objective to determine 
“whether predefined maternal early warning triggers (MEWT) can predict pregnancy morbidity” 
(p. 337), and the aim of the study was to evaluate the use of raw clinical vital signs, values, and 
clinical symptoms assessed over a period of time since there is no established best-practice early 
warning system. A retrospective case-control study followed 50 obstetric patients admitted to an 
intensive care setting throughout seven United States pilot hospitals and 50 obstetric patients that 
had normal delivery outcomes. Eligible patients were of term (and preterm) gestation, and they 
were evaluated in triage and subsequently admitted for treatment during antepartum, intrapartum 
or postpartum timeframes. The patients were admitted to the ICU for vaginal bleeding, 
hypertension, abdominal pain, labor, ruptured membranes, fever, gastrointestinal symptoms, and 
other symptoms that required evaluation. The six MEWTs evaluated were heart rate, mean 
arterial pressure, respiratory rate, oxygen saturation, temperature, and altered mental states.  Of 
the 50 obstetric patients admitted to the ICU, 12% were diagnosed with pre-eclampsia.   
Results showed that the presence of two or more MEWTs warranted further evaluation/or 
escalation of notification of the obstetric provider. The authors could conclude that MEWTs 
seemed to separate normal obstetric patients from candidates who presented with a clinical 
condition that warranted an intensive care admission for monitoring this indicates their use might 
reduce maternal morbidity (Hedriana et al., 2015). The strength of this study lies in its enabling 
normal vital sign values to be discriminated against abnormal values as evidenced by the fivefold 
lower rate of false-positives in the control group, as well as the 50 patients who had a normal 
delivery outcome. Limitations of the study include a/the small sample size, the nonrandomized 
design, and the lack of prospective data analysis (Hedriana et al., 2015).  
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Expanding on the benefits of EWS’s here in the United States, Shields et al. (2016) 
assessed whether a reduction in maternal morbidity could occur through the implementation of a 
maternal early warning trigger (MEWT) tool that was designed as a clinical pathway tool. 
Sepsis, cardiopulmonary dysfunction, preeclampsia-hypertension, and hemorrhage, the four most 
common maternal morbidities, were the maternal conditions the tool addressed. Assessments and 
management recommendations for these conditions were also built into the pathway to 
streamline decision making. The pilot tool was implemented in 6 hospitals that are part of a large 
hospital system. The other obstetric sites for the system served as “non-pilot” sites during two of 
the study time periods. The CDC defined severe maternal morbidity, composite maternal 
morbidity, and ICU admissions were used as the outcome measures. The study was conducted 
with two time intervals to analyze the effect of the MEWT tool: a 24-month baseline control 
period and a 13-month MEWT study period. A total of 183,191 deliveries were involved in this 
study that subsequently resulted in significant reduction in maternal morbidity (P < 0.01) and 
composite morbidity (P <0 .01). The three most favorable components of the tool are identified 
as: low alarm frequency and reasonably good predictive value for patients admitted to intensive 
care units; also, it was tested in hospitals with a wide range of annual deliveries.  There were no 
changes to ICU admissions. The authors report that the nonpilot sites were unchanged with the 
CDC severe maternal morbidity, composite morbidity, and ICU admissions between baseline 
and the post-MEWT testing period. The authors concluded that the “variation in hospital delivery 
services at the pilot sites suggests that this maternal early warning tool would be suitable for use 
in the majority of maternity centers in the United States” (Shields et al., 2016, p. 527). 
Despite the benefits of the EWS mentioned in the above studies, there are still several 
obstacles to overcome. When designing the study, the paper scoring systems should use the “less 
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is more” approach, as suggested by Christofidis, Hill, Horswill, and Watson (2015). The authors 
report that the speed and accuracy within which chart-users determine patient’s early warning 
scores needed to be evaluated. Novice chart-users (n=47) were given vital signs to record on 
various types of charts. Their findings suggest that the fastest recordings—with fewest 
documentation errors—occurred while using a simple chart design without individual scoring 
rows. The data for complex patients yielded greater response times and greater error rates on all 
three of the chart designs.  
 Electronic Early Warning Systems. Behling and Renaud (2015) developed an Obstetric 
Vital Sign Alert (OBVSA) as their EWS that hinged on a points system derived by 
documentation in the EHR. The OBVSA uses 6 critical values which are assessed and scored per 
established ranges 2 deviations above or below normal ranges. A calculated risk score displays 
visual cues on a dashboard, so the obstetric staff can monitor the patients for postpartum 
hemorrhage. As a patient’s assessment changes, the values change on the display for constant 
review. The goal was to quickly identify women who are at risk for clinical compromise and to 
increase the staff’s critical thinking level in order to stimulate and encourage effectiveness in 
addressing clinical issues. The database consisted of women who were diagnosed with 
postpartum hemorrhage during the 8 months of pre-implementation of the OBVSA, and it 
yielded 44 charts for inclusion. The same inclusion criteria yielded 50 charts during the post-
implementation time period. Results of the OBVSA resulted in reduced symptom-to-intervention 
time in the postpartum hemorrhage patient population. The implications for future practice 
include switching from EWS tools that were previously print/paper-based as well as to begin to 
let the EHR collect and display real-time data for patient assessment and improved outcomes.  
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  Schmidt et al. (2015) performed a pragmatic, retrospective, observational study to see if 
the implementation of a specifically designed computerized program would improve the 
processes around the recognition of, and response to, patient deterioration. This study was not 
piloted with obstetric patients, but it did use three main specialties. However, within further 
studies, the results may be generalized as the “electronic physiological surveillance system 
(EPSS), was designed to improve the collection and clinical use of vital signs data, reduced 
hospital mortality” (Schmidt et al., 2015, p. 10). The findings suggest that a system like the 
EPSS can improve both processes and patient outcomes. Schmidt et al. (2015) do warn that a 
direct cause-and-effect relationship between the two cannot be established; yet, they confirm that 
results from two different sites support that the findings of the study are significant.  
The United Kingdom has conducted hallmark studies and subsequently offered 
recommendations for maternity early warning systems through the use of national committees 
and the Obstetric Anesthetists’ Association. After years of encouraging the use of a MEOWS, 
the United Kingdom’s recommendations have been implemented globally, albeit in different 
versions. Within the United States, vigorous ongoing research is occurring that examines the 
importance of the use of early warning systems and their ability to detect a patient’s clinical 
deterioration; however, this research trend does not include examination of obstetric patients. By 
2014, The National Partnership for Maternal Safety gathered obstetric providers, here in the 
United States, to propose the use of maternal early warning criteria, and the committee made 
suggestions relating to parameters obstetric teams should consider. Collectively, within these 
studies, limited data exists to suggest that the use of these types of clinical assessment tools can 
reduce maternal morbidity (Mackintosh et al., 2014; Shields et al., 2016).  
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Freidman (2015) performed his own analysis of maternal early warning systems in order 
to document progress in improving maternal morbidity and mortality within the United States. 
The objective was to review the following strategies that improve maternal outcomes: clinical 
rationale for EWS including research literature from other specialties, clinical parameters and 
recommended care in maternal EWS’s, research evidence to support use of a MEWS, and future 
directions for optimizing and validating MEWS’s. Friedman (2015) recommends to the obstetric 
community includes optimization of the alert system performance to avoid false-positive results 
and to avoid nuisance alarms. Within the systematic review of research evidence, Freidman 
(2015) found that the United Kingdom’s MEOWS alert parameters may detect hemorrhage, 
sepsis, preeclampsia, and cardiovascular complications. The simplified version of the MEOWS 
from the United States, the MEWC, offers a one-trigger prompt for bedside assessment. Maternal 
early warning systems are favorable for reducing severe maternal morbidity and mortality if 
identification of patients at risk for critical illness result without a high number of false-positive 
alerts (Friedman, 2015). 
Synthesis of Evidence  
 Despite recommendations from the United Kingdom for use of a maternal early warning 
system, a validated tool geared specifically for the obstetric population does not exist (Isaacs et 
al., 2014; Swanton et al., 2009). Early warning systems are utilized, within other populations, 
with successful recognition of clinical deterioration (Edwards et al., 2016). The National 
Partnership for Patient Safety began to evaluate vital sign changes in the obstetric patient to 
develop a tool for recognizing deteriorating conditions for this population (Mhyre et al., 2014). 
To implement a MEWS in antepartum, intrapartum, and postpartum settings, a single-parameter 
scoring system may be more practical than an aggregate-weighted scoring system (Mhyre et al., 
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2014). Parameters considered for the MEWS are specific to blood pressure, heart rate, 
respiratory rate, oxygen saturation, urinary output if an indwelling catheter is in place, and 
altered mental status. Additionally, a MEWS algorithm would identify patient conditions that 
would prompt a bedside assessment by providers who could activate resources required for 
diagnostic and therapeutic interventions. Improving systems to recognize and treat early 
indicators of maternal complications may prevent, or reduce, the severity of these situations 
(Mhyre et al., 2014).   
Gap in Literature 
Strong evidence exists highlighting the morbidity and mortality of hypertensive disorders 
of pregnancy, and that treating severe range blood pressures with an antihypertensive in a timely 
manner improves patient outcomes. Also, EWS have been in use in service lines outside of 
obstetrics with proven success. Utilizing the workflow and trends of EWS’s, several formats of 
MEWS have been developed as paper tools for abnormal patient assessment parameters. 
Researchers agree that the MEWS standard should be simple, meaningful, and effective in 
promoting the avoidance of false-positive alerts.  The literature was sparse relative to the 
evaluation of how the EMR, and real-time documentation by bedside staff, could be utilized as 
an EWS to detect a patient’s clinical deterioration with the obstetric patient population. Notably, 
limited data exists for Level I-III evidenced based literature involving obstetric patients. This is 
certainly justified, as it is prudent to not withhold treatment or interventions that have proven or 
suspected favorable outcomes to conduct Level I-II studies. There remains the need for a 
national standardized and validated tool, whether in paper or electronic version, to be 
implemented for hospitals serving obstetric patients to positively impact morbidity and mortality 
rates.  
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Evidence Based Practice Model 
The Iowa Model of Evidence Based Practice (Appendix H) was used to guide the project.  
Problem-focused triggers include process measures recognizing elevated blood pressures, 
administering an antihypertensive medication within one hour and outcome measures 
(hypertensive patients that experience a stroke or seizure, and hypertensive patients readmitted 
within 30 days). Incidentally, the clinical problem led to a comprehensive literature review on 
early warning recognition tools. The project will pilot the change for implementing an electronic 
early warning system to increase recognition of severe range blood pressures and subsequent 
treatment. 
Theoretical Framework 
The guiding framework for this evidenced based project is outlined by Avedis 
Donabedian, MD, MPH which is commonly referred to as “Structure, Process, Outcome” 
(Donabedian, 1983 & 1988). This model is frequently used when quality assessment is being 
measured, and it is useful in highlighting links between process and outcomes. Quality needs to 
be measured prior to, during, and post implementation of any health care practice change. As 
applied in this scholarly project, structure refers to the area within which care is monitored via 
the EMEWC and is delivered by a provider. Process refers to the interactions between parties in 
which change brings about a result. The EMEWC alarm trigger for elevated parameters and staff 
web-based training for the monitoring program, Cerner® FetaLinkTM, serve as processes in this 
project. Outcomes refer to the changes ultimately produced or the effects of the structure and 
process. Increasing recognition of severe hypertensive episodes, while decreasing time from 
recognition to medication administration, are this project’s ultimate outcomes. Gardner, Gardner, 
and O'Connell (2014) exemplify how the Donabedian framework remains applicable within 
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today’s healthcare models. The authors found success with establishing relationships between 
structure, process, and outcomes through nursing service innovations which laid the groundwork 
for safe, effective, and patient-centered care. These three components are evaluated to draw 
conclusions about quality of care as summarized by Donabedian (1988): “good structure 
increases the likelihood of good process, and good process increases the likelihood of good 
outcome” (p. 1745). 
Summary   
It is difficult to recognize that an obstetric patient’s condition is deteriorating, because 
normal physiological changes in pregnancy generate significant shifts in maternal vital signs. 
Literature reveals that 40-50% of maternal deaths can be attributed to delays in recognition, 
diagnosis, and treatment including deaths from hypertensive disorders (Cantwell et al., 2011; 
Lawton et al., 2010).  ACOG (2015b) recaps and advises that adverse outcomes often occur 
because of failed system deficiencies or inadequate safety measures which are in place to prevent 
error/s. The use of EMEWC will assist with establishing standardization of care by decreasing 
variation in nurses’ and providers’ recognition and treatment plans.  
The time has come to leverage the use of technology to improve clinical outcomes. 
Through bedside monitoring functionality of the Cerner® FetaLinkTM program, clinical 
parameters can be established, and notifications can alert the nursing staff when patients present 
outside of the desired range. The healthcare system, overall, has experienced a reduction in adult 
mortality by utilizing Cerner® to recognize a patient’s clinical deterioration though alerts 
designed to identify abnormal parameters established for sepsis recognition. The healthcare 
system is ready to share a variety of the lessons learned, via its use of Cerner®, to other 
disciplines and various other patient conditions. The purpose of this project is to evaluate 
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whether the use of the electronic maternity early warning criteria (EMEWC) improves rates of 
treatment of severe range blood pressures, within one hour, through the recognition of abnormal 
vital signs and notification prompts to providers.   
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Chapter III: Methodology 
Needs Assessment 
Prior to the implementation of this project, the hospital had been working to increase its 
compliance rate in treating patients’ first severe range blood pressure. Provider and nursing 
education as related to the treatment standard, developing antihypertensive protocols in order for 
providers to have easy access to evidence based guidelines, and reporting outcomes at the 
hospital level have been implemented within the last eighteen months of this study. A literature 
search was performed/implemented to gain insight about the tools that are typically utilized to 
recognize deteriorating patient conditions and improve patient outcomes. The key stakeholders 
include the nursing staff, the providers, hospital administrators, the quality department, and, 
finally, the information services division.  
Project Design 
Purpose. The purpose of this evidence based project is to determine if the use of the 
EMEWC will increase treatment of severe range blood pressure—within one hour of 
recognition—in a cohort of hypertensive obstetric patients hospitalized in L&D and HROB units.   
Question. The guiding PICO question follows: In hospitalized obstetric patients with a 
hypertensive diagnosis (P), will the use of the EMEWC (I), measured pre-and post-
implementation (C), increase the rate of an antihypertensive medication administered within an 
hour of a patient’s severe range blood pressure occurrence (O)? 
Design. Data collection will occur on all obstetric patients in L&D and HROB units at 
the project facility with severe hypertension blood pressure readings. Pre-and post-
implementation data will be evaluated.    
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Participant Setting and Sample. The project facility is a regional 457-bed, not-for-
profit medical center located in the southern piedmont region of North Carolina, in the United 
States. The project facility delivers approximately 240 patients per month, and it serves patients 
of all races, ages, and pregnancy complications; additionally, it is a referral center for the 
surrounding five-county area. The labor and delivery (L&D) unit has 12 suites, 4 triage bays, and 
2 operating rooms. The 8-bed high risk obstetric (HROB) unit admits antepartum and postpartum 
patients, as well as patients who are readmitted for a pregnancy complication within 30 days of 
discharge. Care is coordinated between obstetrics and gynecology (OB GYN) hospitalists, 
private practice OB GYNs, family practice attendings and residents, and two maternal fetal 
medicine providers as well as five neonatologists who accept patients into the Neonatal Intensive 
Care Nursery as early as 26 weeks’ gestation.  
All obstetric patients admitted to L&D and HROB with a severe range blood pressure 
(sBP 160 mm Hg or higher and/or dBP of 110 mm Hg or higher) will be included in this 
evidence based practice project. All the population will be measured; therefore, no random 
selection is required.  Inclusion criteria are as follows: an inpatient obstetric admission to the 
L&D and HROB units regardless of the patient’s pregnancy status; an ICD 10 patient diagnosis 
of any level of classification of hypertension in pregnancy; a patient’s first severe blood pressure 
at any point during their inpatient admission; all maternal patients, regardless of age, parity, 
gestational age, insurance status, provider group, and/or any level of co-morbidity. Exclusion 
criteria are as follows: patients who deliver within one hour of the inpatient admit date and time, 
an obstetric patient in the operating room, or in an intensive care bed space. Patient data that is 
triggered by Cerner® FetaLinkTM will be evaluated and confirmed through nursing assessment of 
the patient before interventions will be implemented.  
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Measures. The process measure for this project is to evaluate the percentage of patients 
who received an antihypertensive medication within one hour of the onset of a severe range 
blood pre-and post-implementation of the EMEWC. The goal, 3 months following post-
implementation of the EMEWC, will be a 60% rate of administration of an antihypertensive 
medication within one hour of the onset of a severe range blood pressure.  
Protocol. The steps of the project follow: 
1. Information Services will coordinate the installation of the Cerner® FetaLinkTM program 
on the hospitals nursing units of L&D and HROB in November 2016.  
2. A web-based tutorial for the Cerner® FetaLinkTM program will be secured, from 
Cerner®, to train all nurses hired on L&D and HROB units. The training module will be 
assigned to each staff through their PeopleLink@CHS talent management system that 
tracks educational requirements of staff.  
3. This will be an interactive web-based training module that reviews the functionality of 
systems including how to address alerts and how/ways to document annotations 
(Appendix I) which will take approximately 30 minutes to complete.  
4. The staff will be given a case scenario to complete, at the end of the module, that will 
demonstrate how the objectives of the program were met. Once the training objectives 
have been met, a certificate of completion will be printed, at the end of the module, that 
will be submitted to the manager. A roster will be kept, by the nurse management team, 
to ensure accountability of module completion by all nurses before they can work on the 
unit post-implementation of Cerner® FetaLinkTM.  
5. The Project Lead will serve as a resource for staff, to encourage and support training, and 
he/she will be a resource post-implementation of Cerner® FetaLinkTM.  
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6. After training, the Cerner® FetaLinkTM program will be “activated” on both L&D and 
HROB bed spaces.   
7. Within Cerner® FetaLinkTM, the upper bound parameter alarms will be set for blood 
pressure readings: systolic greater than and equal to 160 mm Hg and diastolic greater 
than and equal to110 mm Hg. 
8. If a patient’s condition meets the upper bound limits of sBP 160 mm Hg or higher, and/or 
dBP of 110 mm Hg or higher, an audible alert will sound. The nurse will confirm the 
patient’s condition via a bedside assessment, and he/she will document appropriate 
annotations for monitoring and treatment interventions (Appendix J).  
9. For a severe range blood pressure, the nursing staff will recheck the patient’s blood 
pressure to confirm the sustained elevation.  
10. If the patient’s first severe range blood pressure remains elevated for greater than15 
minutes, the nurse will notify the provider of the patient’s condition and obtain an order 
for an antihypertensive treatment medication. This patient will be captured in the 
protocol, and she will be monitored for the medication administration time.   
11. If the patient’s severe range blood pressure doesn’t not remain elevated for greater than 
15 minutes, the nurse will continue to monitor the patient throughout her daily workflow. 
This patient would not be included in the measure due to the fluctuation in her blood 
pressure measurement.  
12. The Cerner® EHR serves as the source of data. A SAP® BusinessObjects report, built by 
the Dixon Advanced Analytics team, within the healthcare system, will pull patient data 
medical records per the inclusion and exclusion criteria. The report highlights the date 
and time of the patient’s severe range blood pressure readings, as well as the date and 
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time of administration of the first antihypertensive medication. The reports developed by 
Dixon Advanced Analytics are validated against the medical record documentation at the 
time of the build.  
13. A patient’s date and time of a severe range blood pressure will be evaluated against the 
patient’s medication administration record for timing of an antihypertensive medication.  
14. A fallout will be assessed if the antihypertensive medication was administered greater 
than 1 hour of the first severe range blood pressure.  
Analysis Support. The mentor for statistical support will be Dr. Julie Thompson from 
Duke University. As project lead, I calculated project statistics, and Dr. Thompson confirm the 
results. Professors at the East Carolina University College of Nursing were also available to help 
guide the statistical analysis upon request.  
Data Collection and Analysis. Data collection occurred on all patients at the project 
facility with a diagnosis of hypertension during pregnancy. Descriptive statistics (N, %) were 
evaluated for patients who received an antihypertensive medication within one hour of a severe 
range blood pressure in order to determine if the goal (60 %) was met after three months. These 
patients were labeled as “treated”. If the patient was not administered a medication within one 
hour of the elevated severe range blood pressure, the label of “not treated” was applied. A 2-x-2 
Chi-Square Fisher’s Exact test was conducted to compare the rate of administration of the 
antihypertensive medication for a severe range blood pressure, before and after implementing 
the electronic early warning system, through the Cerner® FetaLinkTM program.  
Baseline data for 2016 is a 15.5% rate for administering an antihypertensive within one 
hour of the onset of a severe range blood pressure. Data was collected, retrospectively, for three 
months’ post implementation of the EMEWC. No demographic data will be collected for this 
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project, as severe range blood pressures can occur with any pregnant patient either pre-or post-
delivery. The data will have patient identifiers that include the medical record number, and the 
patients account number, per the build of the data abstraction tool. The Hypertension Report that 
will be populated with data abstraction from the EHR that will have patient identifiers will be 
secured within the PI’s Microsoft Office 365 password protected account; this account is 
provided by the healthcare system’s Information Services department. No consents, tools, forms, 
or papers will be required for this project.  IBM SPSS (2013) will be used for statistical analysis 
after patient identifiers have been removed. Alpha will be set to .05.   
Limitations. The use of “non-equivalent” assignment acknowledges that the 
investigator did not control the assignment into the project; therefore, the groups’ pre-and post-
intervention participant’s numbers may be different. Of specific note, here, is that any prior 
differences could potentially affect the project’s analysis. This set up could lead to the 
conclusion that the EMEWC did not make a difference when it actually did, or the opposite 
could be true, and results could presume that the EMEWC did make a difference when it, in fact, 
did not.  
 
Future Plans 
A long-term set of outcome measures, that will not be realized during the specific 
timeframe of this project, will be used to evaluate the number of hypertensive patients that 
develop a stroke, hypertensive patients that experience a seizure, and 30-day readmission rate for 
postpartum patients with a hypertensive diagnosis. This data is currently monitored through the 
Quality Department with data abstraction occurring periodically. Should the result of this project 
implementation show valued increase in the use of EMEWC, Information Services, and the 
Nursing and the Quality Department, would like to expand the monitoring system to incorporate 
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several signs of clinical deterioration including quantitative blood loss measurements. The 
project has potential to expand to other obstetric facilities within the healthcare system.  
Estimated Resources and Costs 
Cerner® FetaLinkTM software has secured financial support for its purchase and 
installation, and for staff training, from the hospital system. The monitoring of data, and 
subsequent data analysis, will be performed by the Doctorate in Nursing Practice student, and 
relevant information will be incorporated into the Clinical Nurse Specialist role and 
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Chapter IV: Results 
This chapter presents the results of the data analysis which includes sample 
characteristics and major findings. The quality improvement project spans 14 months. The nine-
month pre-implementation period occurred during calendar months January through September. 
The installment, training, and utilization of Cerner FetaLinkTM serves as the implementation phase 
which lasted for two months. The post-implementation phase is represented by three calendar 
months: December, January, and February. Data was collected using a report that analyzed 
obstetric patients’ diagnosis code of hypertension and the date and time of the patient’s first 
severe range blood pressure reading, as well as the date and time of administration of the first 
antihypertensive medication. Due to the automated monthly EHR Hypertension Report, there are 
no missing cases. The small sample size afforded the use of the 2-x-2 Chi-Square Fisher’s Exact 
test to compare the rate of administration of the antihypertensive medication for a severe range 
blood pressure labeled in the data as “treated”.  
Sample Characteristics 
The EHR Hypertension report recognized 103 obstetric patients diagnosed with a 
hypertensive disorder who met inclusion and exclusion criteria. The pre-implementation phase 
included 71 obstetric patients who met criteria in which 11 (15.5%) were treated within one hour 
of the severe range blood pressure. The post-implementation phase included 32 obstetric patients 
who met criteria in which 7 (21.9%) were treated within one hour of the severe range blood 
pressure. Table 1 offers a display of the obstetric patients who were included in the quality 
improvement project, and it denotes the pre-and post-intervention data compared for treatment 
groups. Data for treatment outcomes was collected monthly as noted in Appendix K.  
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Table 1  
 
Antihypertensive Treatment Rates During Pre-and Post-Implementation Phase 
 
Implementation Phase 




within 1 Hour 
Count 60 25 85 
% Not Treated 84.5% 78.1% 82.5% 
 
Treatment 









% Treated 15.5% 21.9% 17.5% 
Total Count 71 32 103 
% Population 100% 100% 100% 
Each subscript letter denotes a subset of PrePost categories whose column proportions do not 
differ significantly from each other at the .05 level. 
 
Major Findings 
The target goal for the project facility was to reach a 60% treatment rate of an 
antihypertensive for patients with a severe range blood pressure. There was a 71% rate of 
increase in patients treated from the pre-implementation phase (15.5%) to the post-
implementation phase (21.9%). The Chi-Square Fisher’s Exact test (Table 2) was utilized to 
evaluate the two categorical variables study phase and treatment outcome from the single study 
population of antihypertensive obstetric patients. A 2-x-2 contingency table was established in 
IBM SPSS (2013) to compare the percentage of treated patients during pre-and post- intervention 
phases. The minimum expected cell frequency was five or greater, so the project did not violate 
any Chi-Square test assumptions. The Chi-Square Fisher’s Exact test indicated no significant 
associations between pre-and-post intervention and treatment timing with an antihypertensive 
medication, X2 (1, n = 103) = p =.42. Although there was an increase in the treatment percentage 
from 15.5% to 21.9%, the improvement was not statistically significant. 
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Table 2 
Chi-Square Tests for Project Significance 
 Value df 
Asymp. Sig. 
(2-sided) 




Pearson Chi-Square .623a 1 .430   
Continuity Correctionb .259 1 .611   
Likelihood Ratio .604 1 .437   
Fisher's Exact Test    .418 .300 
Linear-by-Linear 
Association 
.617 1 .432   
N of Valid Cases 103     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 5.59. 
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Chapter V: Discussion 
Despite efforts to reduce maternal mortality, opportunities remain for improved 
outcomes, as approximately 600 women die annually, within the United States, from 
complications of pregnancy and delivery (CDC, 2016a). Cantwell et al. (2011) find that delays in 
recognition, diagnosis, and treatment of patients experiencing signs of clinical deterioration 
remain significant contributing factors to maternal death/s. Hypertensive disorders complicate 
approximately 10% of pregnancies, and patients with hypertensive disorders often experience 
severe range blood pressures during pregnancy. ACOG (2015a, 2013) recommends treatment for 
the onset of a severe range blood pressure with an antihypertensive medication within one hour 
of recognition. Treating the hypertensive crisis in pregnancy can impact the complications that 
may lead to mortality.  
Limited data exists on the use of EWS in hospitalized obstetric patients.  It was proposed 
that the use of EMEWC can aid in the evaluation of the obstetric patient’s clinical picture and 
alert nursing staff for a bedside assessment in the event of abnormal parameters. The purpose of 
this Doctorate in Nursing Practice quality improvement project is to determine if/whether the use 
of EMEWC will increase treatment of severe range blood pressure, within one hour of 
recognition, in a cohort of hospitalized obstetric patients with a diagnosis of hypertension. The 
project facility realized an increase in the rate of an antihypertensive within one hour of onset of 
a severe range blood pressure in the target population after the implementation of Cerner® 
FetaLinkTM   although the results are not statistically significant.  
Project Results Relation to Theoretical Framework  
The guiding “Structure, Process, Outcome” framework by Donabedian highlights links 
between the three phases for increased quality. Structure was applied in the obstetric units when 
the providers established a standard treatment approach for hypertensive patients with a severe 
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range blood pressure to receive treatment with an antihypertensive medication within one hour. 
Although the standard was in place, the nursing staff were unable to consistently recognize the 
elevated blood pressure specifically due to various forms of input of vital signs into the EHR.  
Process was offered with the implementation of the Cerner® FetaLinkTM program which 
served as an EWS for nursing staff. The program was set with an EMEWC alarm trigger (i.e. 
elevated blood pressures for sBP of 160 mm Hg or higher and dBP of 110 mm Hg or higher). 
The alarm has both distinct audible and visual alerts.  The staff utilized a web-based interactive 
training program in order to familiarize themselves with the software. Throughout the two-month 
dates of implementation, staff were offered individual training on the use of the program, ways 
to address vital signs, and ways to pull the patient data from Cerner® FetaLinkTM into the EHR. 
Outcomes, the changes produced, or the effects of the structure and process, were 
improved for administering an antihypertensive within one hour of a patient’s severe range blood 
pressure. Although not significant, the project facility experienced a 71% rate improvement 
during the three-month post-implementation phase. The staff could increase recognition of 
severe hypertensive episodes when the Cerner® FetaLinkTM program alerted them to a change in 
a patient’s condition. In turn, this decreased the time from severe range blood pressure 
recognition to that of medication administration. This quality improvement project supports the 
Donabedian framework, as relationships were established between structure, process, and 
outcomes.  
Significance of Results to HealthCare 
 The implementation of the Cerner® FetaLinkTM software allowed for patient’s 
deteriorating clinical conditions to be monitored continuously, and it offered the capability to 
alert healthcare staff when parameters for assessments were outside of defined limits. For this 
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quality improvement project, the EMEWC of severe range blood pressures was evaluated 
although this was just one piece of the software’s functionalities. Incidentally, other software 
functions are available to monitor clinical deterioration which include abnormal lab values, all 
aspects of vital signs, patient assessment’s outside of normal defined limits, and fluid volume. 
This project’s focus concentrated on administering a medication to improve outcomes; however, 
data from EWS can serve to improve mortality rates as well as to lower transfers to intensive 
care units from inpatient hospital beds. The key finding for this quality improvement project 
reveals that increasing trends in treatment within an hour for a severe range blood pressure 
should be noted by facilities that are evaluating the implementation of software that scans patient 
clinical conditions in the EHR to improve outcomes.  
 There are national programs that support healthy patient outcomes in obstetrics. Health 
People 2020 (Maternal, Infant, and Child Health, 2016) set target goals to reduce the rate of 
maternal mortality, as well as, the rate of maternal illness and pregnancy complications. The 
Institute for Healthcare Improvement (2017) aims to motivate and build the will for change in 
patient outcomes, identify and test innovative models of care delivery, and ensure the broadest 
possible adoption of proven practices that improve health. To prevent maternal deaths and 
complications that occur during the labor and delivery process, the EHR needs to function in 
partnership with healthcare professionals by utilizing alert functions when signs of clinical 
deterioration are recognized.  As the obstetric community increases its adoption of versions of 
MEWS (Mackintosh et al., 2014; Mhyre et al., 2014; Singh et al., 2012) to identify abnormal 
assessment parameters, the rate of maternal deaths and poor pregnancy outcomes should decline. 
This scholarly project serves as a foundational study that adds to the body of knowledge for tools 
and interventions that improve pregnancy outcomes using electronic MEWS.   
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Project Strengths and Limitations   
 Strengths. Several strengths of the project were specifically identified. Cerner® 
FetaLinkTM software allowed customization of within normal limits parameters. The project 
facility set the EMEWC for elevated sBP at 160 mm HG and for dBP of 110 mm Hg. If a 
patient’s clinical data hit either elevated parameter, a visual cue appeared on the Cerner® 
FetaLinkTM, and it emitted a distinct audible alert that was both seen and heard in the patient’s 
hospital room and at each nursing station. The parameter was easily agreed upon via support 
within the literature. The project facility’s obstetric providers had also agreed upon a treatment 
standard of care of severe range blood pressures that included specific antihypertensive 
medications, dosages, and routes of administration. The pharmacy had also approved the 
standard of care treatment, and it had placed all the appropriate medications on override so that a 
nurse could administer them without any delay.  The specific defined severe range blood 
pressure alerts, providers’ approving one treatment standard of care, and the pharmacy’s working 
with the team to accept nursing oversight for medication management allowed this quality 
improvement project to focus on the new tool: Cerner® FetaLinkTM intervention to assess rates 
of improvement in the antihypertensive medication administration.  
 An additional strength can be attributed to the use of the Hypertension Report that pulled 
data from coding, then pulled blood pressures, followed by medication names with dates and 
times of administration. Objective data is “clean” and free of researcher bias. The patients in the 
population met all inclusion and exclusion criteria, and the results could be replicated by any 
other investigator.  
 Limitations. Limitations of the study may have impacted the less than significant 
outcome. The project’s population was pulled by the EHR Hypertension Report which pulled 
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final diagnosis coding which occurs after a patient’s discharge. The first severe range blood 
pressure may have occurred early into the patient’s inpatient admission before a hypertensive 
diagnosis was suspected. In this case, nursing staff would not be following the hypertensive 
treatment standard of care and may have missed the one-hour window of administration time.  
 Cerner® FetaLinkTM functions in a manner in which delays can occur. Although vital 
signs are automatically assessed by the software, the data must be recognized and verified by a 
nurse which allows the crossover from the program to the EHR for the date and time stamp the 
data was collected. At that point, the audible and visible alert would fire for abnormal 
parameters. Timing of data entry impacts alerts, and the subsequent care will be provided.  Both 
delays in recognition of hypertensive coded patients, and data recognition and verification of 
vital signs, may have impacted the project’s outcomes.  
 Limitations also occur in the form of lessons learned during a project’s implementation.  
Staff training and go-live support on new equipment must be multifaceted. The web-based 
training was helpful but not realistic, and it could not identify every circumstance a nursing staff 
member may encounter with their patients. The training included information on hardware, 
software, functionality and charting; whereas, this project’s focus was on the recognition, 
verification, and entering of blood pressures. Perhaps one function of an intervention could have 
been hard-wired instead of a large software upgrade where bits and pieces of training were 
remembered. Go-Live support was provided by Information Services staff for two weeks around 
the clock. Despite best efforts, each nurse was not able to use the Cerner® FetaLinkTM software 
to its full potential during that time. Training was continued, with individual nurses, as requested 
by staff, and during shift-huddles to educate individuals and address frequently asked questions 
and quality reports pulled from the software.  
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 Another lesson learned by this project lead is that projects may have set time criteria 
where pre- and post-intervention phases cannot be equal. In this project, the nine-month pre-
intervention allowed for many points of data to be collected. Within time constraints to complete 
this Doctorate in Nursing Practice quality improvement project, only a three-month post-
intervention phase was evaluated. The short time frame allows for a rate to be determined to 
meet project terms, but a longer post-implementation period may have lead statistically 
significant results.  
Benefit of Project to Practice         
The contribution of this quality improvement project is that it supports the growing need 
for utilizing EWS to improve patient outcomes. More specifically, EMEWC, within those EWS, 
can identify clinical deterioration in the obstetric population that is often omitted from quality 
initiatives. Although the project facility aimed to achieve a 60% rate of an antihypertensive 
medication within one hour of a severe range blood pressure, a 71% rate of increase of patients 
treated from the pre-implementation phase (15.5%) to the post-implementation phase (21.9%) 
was achieved. It is important to note that blood pressure is just one data point that was being 
evaluated which serves as a foundational study toward developing an electronic MEWS. There 
exists the ability, with EMEWC, to set parameters on assessments that include pain scale, 
temperature, heart rate, respiratory rate, quantitative blood loss, and lab values along with any 
documented nursing physical assessment detail. This could lead to assisting with other maternal 
mortality complications of pregnancy and delivery that include hemorrhage, seizures, and 
infections. It is important, now, to focus specifically on availability the EHR identify signs of 
clinical patient deterioration, alert the healthcare staff to intervene, and to conduct a bedside 
assessment as well as to develop a treatment plan.  
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The American Association of Colleges of Nursing Essentials of Doctoral Education for 
Advanced Nursing Practice (2006) outlines eight core competencies that programs must address. 
This scholarly project was conducted to assist with fulling the requirements of the DNP program 
at East Carolina University. In conjunction with other DNP didactic courses and objectives, each 
DNP essential was addressed as identified in Appendix L. I am obligated as a DNP to continue 
with a scholarly approach to the nursing discipline and will commit to advancing the profession 
through implementing additional quality improvement initiatives. This project serves as a 
training process so that I can continue to advance nursing practice and impact patient outcomes. 
Recommendations for Practice 
 Practice. The results of this project trend, within a favorable direction, toward the use of 
EWS to aid in identifying clinical deterioration. Nursing staff need to incorporate trends in 
patient assessment findings, and apply critical thinking skills on how to intervene when a 
patient’s condition warrants. As nurses grow professionally they often change positions which 
lends newly-hired staff to remain on the night or weekend shifts where fewer hospital resources 
and seasoned peers, are readily available for consultation and intervention. The EWS can well be 
an additional tool to assist with staff who are less experienced and often those who lack certain 
critical thinking skills.  
 Education. The nursing discipline can incorporate low or high-fidelity simulation into 
assessment and intervention training. This can be achieved in nursing schools as well as to hone 
skills of nurses already in the profession for ongoing training. Simulation training can 
incorporate changing patients’ conditions to bring awareness to assessments and subsequent 
interventions for each. An EWC should aid in the identification of clinical deterioration, and, 
notably, it should not be the first line of assessment in patient care.  
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 Policy. Depending on the use of an EWS, most parameters and alerts will need to be 
based upon evidence based standards and guidelines. Policy and clinical standards may need to 
be developed or approved to identify a standard of care or parameters for within defined limits. 
That policy or practice will be used by a facility’s Information Services team to set software 
alerts for patient conditions that fall outside of normal values.  
 Research.  The United Kingdom was the first nation to extend efforts to develop a 
national plan to address maternal mortality. It has taken years to develop, but this body of 
research is beginning to evaluate obstetric early warning systems and scores or tools that will 
assist with recognizing clinical deterioration. I believe future research should continue to work 
towards developing a national standard of care for identifying changes in conditions in 
obstetrical patients, and it should offer a subsequent set of standard interventions to that specific 
end. An example would be for an obstetrical patient with a hypertensive diagnosis who has a 
severe range blood pressure--not only would the EHR alert staff, but it would assist with 
ordering the antihypertensive medication and check lab values. If a liver function test had not 
been ordered, a task could trigger it to place an order to collect labs. Everything would be 
documented electronically. Finally, in the opinion of this researcher, it appears time the EHR 
works to coordinate all the entries to identify patient trends with a goal of improving each and 
every maternal outcome.  
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Appendix C 
Carolinas HealthCare System IRB Determination  
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DNP Scholarly Project Time Line 
 
  




Carolinas HealthCare System NorthEast Perinatal Quality Committee  
Maternal Early Warning Criteria 
 
  
CHS NE Perinatal Quality Committee and OB Department  
Parameters for EHR Value 
  Low High 
Temperature 96.9 >100.4 
Blood Pressure-systolic  <80 >160 
Blood Pressure-diastolic   >110 
Heart Rate <50 >120 
Respiratory Rate <10 >30 
Oxygen Saturation %-room air <95%   
Oliguria (mL for >2 hours) for catheterized patient <30   
Quantitative Blood Loss-C-Section   >1000 
Quantitative Blood Loss-Vaginal   >500 
Maternal agitation, confusion, unresponsiveness if any present 
Preeclampsia, with patient reporting non-remitting headache or 
shortness of breath if any present 













Sample Size, & 
Setting 
Study findings that help 
answer the EBP question 
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71% response rate 
80% median usefulness score for 
standardized national obstetric EWS 
The survey supports CEMACH 
recommendations for a nationally 
agreed obstetric EWS.  
30 units (19%) currently use any form 
of obstetric EWS 
 Survey to assess 
opinions on the value of 
an EWS validated for 
the obstetric population, 
how it could be 
implemented plus a 
comments section.  
Obstetric Anaesthetists’ 
Association (OAA) led the 
survey to address the 
recommendation by the 
United Kingdom’s 
Confidential Enquiries into 
Maternal and Child Health 
(CEMACH) to improve 
patient care through the use 
of an EWS.   
AIM: to collate opinions on 
the value and ease of 
implementation of an 
obstetric-specific system to 
discover what systems are 
currently in use in facilities 
in the United Kingdom 





29 charts of women 
admitted to an ICU  
10% of cases were deemed preventable 
Most frequent types of preventable 
events were: inadequate 
diagnosis/recognition of high-risk 
status, inappropriate treatment, 
communication problems, and 
inadequate documentation.  
The sample was 
small and from a 
single site.  
 
Case reviews of severe 
acute maternal 
morbidity (SAMM) 
AIM-to conduct a 
retrospective audit of 




preventability to measure 
the quality of maternal care 
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 For many patients in this review, 
sepsis and hemorrhage modified early 
obstetric warning system (MEOWS) 
alerts had the potential to improve 
outcomes through early recognition. 
Combination of physiologic and 
neurologic parameters assist with 
identification of parameters of clinical 
deterioration in hypertensive disorders 
and other conditions leading to 
mortality.  
Case reviews of maternal deaths show 
that early warning signs of impeding 
maternal collapse went unrecognized. 
Recommends hospital-based adoption 
of MEOWS as a “top ten” requirement 
and urges leadership and policy 
makers to introduce and audit 
MEOWS as soon as possible.  
 Parameters for RR, 
HR, Pain, Oxygen 
Saturation, T, BP, & 
Neurologic Response 
are assigned abnormal 
values depending on 
severity a yellow alert 
or red alert is scored. A 
clinical response to 
urgently assess the 
patient’s status will 
fire for 2 yellow or 1 
red trigger.  
8th report (2007) United 
Kingdom’s CEMACH’s 
triennial report (Saving 
Mothers’ Lives) on 
maternal death 
recommends adoption of 
the MEOWS 
Routine use in all pregnant 
or post-partum women who 
become unwell to facilitate 
more timely recognition, 
referral and treatment of 
women who have, or are 
developing, a critical 
illness.  
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ICU admissions at a 
university hospital 
Reykjavik, Iceland.  
65 patient’s records 
over 3-month period 
Observations were documented in the 
medical record in various percentages: 
Respiratory rate =14%, urinary output 
= 40%, level of consciousness = 48%; 
temperature= 69%, and oxygen 
saturation = 80% 
Increased respirations were the most 
frequent precursor to clinical 
deterioration in patients prior to 
admission to the ICU and was at the 
same time the parameter that was most 
poorly documented.  
With better monitoring and 
documentation of physiological 
parameters, emergency admission to 
the ICU might be avoided.  
The sample was 
small and from a 
single site.  
Obstetric patients 





Data collection, chart 
review for 
documentation of vital 
signs prior to clinical 
deterioration 
AIM: to estimate the accuracy 
of nursing documentation per 
parameters that comprise 
MEWS in patients prior to 
emergency admission to the 
intensive care unit (ICU).  
Nurses to need be alerted to 
the necessity of documenting 
early signs of deterioration of 
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gestational ages 20 
weeks’ to 6 weeks 
postpartum 
200 (30%) triggered 
abnormal measured 
parameters  




pregnancy or infection 
Modified Early Obstetric Warning 
System (MEOWS) was 89% sensitive 
(95% CI 81-95%), 79% specific (95% 
CI 76-82%) with a positive predictive 
value 39% (95% CI 32-46%) and a 
negative predictive value of 98% (95% 
CI 96-99%).  
Morbidity (94%)  driven by 3 
conditions: hemorrhage, preeclampsia, 
and infection 
A valuable screening tool is one that is 
cost effective, safe and validated 
The MEOWS demonstrated a much 
higher sensitivity than non-obstetric 
early warning systems that are in use 
in adult populations.  
Conclusion: Useful tool for predicting 
maternal morbidity 
Not designed to determine MEOWS 
efficacy in detecting acute critical 
illness, improving management of 
morbidity (time to administration of 
antihypertensives) or improving 




triggers are set 
close to the 
values that define 
morbidity (a 
positive trigger 
that is associated 
with morbidity 













Limits were set for 
MEOWS parameter for 
triggers: Temperature, 
BP, Heart Rate, 
Respiratory Rate, 
Oxygen Saturation, 
Pain Score, and 
Neurological Response.  
Each parameter 
documented at least 
every 12 hours; a 
trigger was assessed if 
an abnormal parameter 
was documented.   
AIM: To evaluate the MEOWS 
as a tool for predicting 
maternal morbidity by 
measuring its sensitivity, 
specificity, and predictive 
value.  
The 2003-2005 triennial 
Confidential Enquiry into 
Maternal and Child Health 
(CEMACH) recommended the 
routine use of the MEOWS 
which is adapted for the 
obstetric population.  
Definition of morbidity 
included hemorrhage, severe 
preeclampsia, infection, and 
thromboembolism. 
This is a paper tool.  
No previous studies have 
validated the charts although 
the tool is in use in the United 
Kingdom.  
This is the first study 
attempting to validate an 
obstetric early warning chart.  
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Intensive Care Units in 
the United Kingdom, 
Wales and Ireland 
submit data to the 
National Audit and 
Research Centre 
(ICNARC) Case Mix 
Programme (CMP). 
71, 108 females aged 
16-50 were randomly 
divided into Set 1 and 
Set 2. Set 1 became 
the model 
development set and 
used 2240 direct 
admissions to ICU. Set 
2 became the 
validation set with 
2200 direct obstetric 
admissions to the ICU.  
 
 
The new clinical obstetric early 
warning score has an excellent ability 
to discriminate survivors from non-
survivors in this critical care data set.  
Compared the statistical EWS and 
clinical EWS with Swanton et al.’s 
empirically designed MEOWS; the 
Confidential Enquiries into Maternal 
Deaths obstetric EWS and the Royal 
College of Physicians’ non-obstetric 
National EWS 
Mortality rates are presented with 
Clopper-Pearson 95% CI and the 
effects of predictor variables as odds 
ratios with 95% CI. Statistical 
significance was defined for two-sided 
p<0.05. 
Swanton et al. Modified Early 
Obstetric Warning System, 0.937 (95% 
CI 0.884-0.991) for the obstetric early 
warning score suggested in the 2003-
2005 Report on Confidential Enquiries 
into Maternal Deaths in the United 
Kingdom, and -0.973 (95% CI 0.957-
0.989) for the non-obstetric National 






due to mechanical 
ventilation 
Physical variables 
collected during the 
first 24hrs of critical 
care admission  
Logistic regression for 
mortality in the model 
development set was 
used to create a 
statistically based early 
warning score.  
  
Physiologic variables 
that could be presented 
by a patient outside an 
ICU were selected: 
heart rate, blood 
pressure, respiratory 
rate and temperature.   
 
 
AIM: to design and validate 
an aggregate weighted early 
warning scoring system for 
obstetric patients 
Used EWS parameters to 
predict death for patients 
with obstetric diagnosis 
admitted to ICUs.  
Pre-existing empirically 
designed early warning 
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maternity unit in 
Auckland City 
Hospital in New 
Zealand 
Random sample of 
women pregnant or 
within 6 weeks 
postpartum and 
admitted to ICU or 
CVICU or obstetric 
high dependency unit. 
N=42 admissions to 
ICU 
N=71 admissions to 
obstetric high 
dependency unit 
The EWS might have reduced the 
seriousness of maternal morbidity in 
five cases (7.6%) including 3 
admissions due to sepsis and 2 due to 
hemorrhage.  
Findings can advocate for the 
introduction of an EWS in the 
maternity service line 
Interpretation of validity and 




and the EWS was 
applied to 
determine if care 
could have been 
improved.  
The sample was 
small and from a 
single site.  
This study did not 
allow the 
determination of 
how often an 
EWS might have 
led to either 
delayed 
escalation due to 
low scores or 
unnecessary 




Case review and 
transcribed observation 
charts, group consensus 
determined whether 
EWS might have 
hastened the recognition 
and or escalation and 
effective treatment 
AIM: to determine 
whether as EWS may 
have improved the 
detection of severe 
maternal morbidity or 
lessened the severity 
of illness among 




there is incomplete 
recordings of basic 
clinical parameters in 
particular respiratory 
rate. 
An EWS may address 
the issue of 
incomplete recordings, 
especially attention to 
the importance of 
measuring respiratory 
rate and reducing 
severe morbidity.  
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Tools in use: 
MEOWS-58 (45%) 
Modified Version-65 (50%) 
Different System-7 (5%) 
Consistent Physiologic Parameters 
Monitored: 
T, HR, RR, BP, Urine Output, 
Proteinuria, Lochia, Capillary 
Refill 
This study deemed 4 parameters 
as essential in recognizing clinical 
deterioration: HR, RR, BP and T 
Suggested Updates to Physiologic 
Parameters:  
Blood Sugar, Responds to Voice, 
Alert, Responds to Pain, 
Unconscious, Oxygen Saturation 
Barriers to Implementation: 
Staffing pressures, lack of support 
from midwives and lack of 
education, training and audit 
MEWT tool in this study included 
recommendations for patient 
assessment and treatment. 
The tool was sent 
to Anesthetists 







which tools help 
with improving 
communication 
with the health 
care team 
members.   
Survey (adapted from 
2007 survey previously 
administered) that 
included free text 
comments and 
requested a copy of the 
facilities currently used 
EWS 
 
AIM: The Modified 
Obstetric Early Warning 
Systems (MObs) Research 
Group (United Kingdom) 
aimed to identify which 
EWS are currently in used in 
obstetric practice and which 
physiological parameters are 
included, and to describe 
problems associated with 
EWS.  
100% of the facilities 
reported use of an EWS in 
maternity wards which is in 
an increase from the 19% 
reported in 2007.  
  









Study findings that help 
answer the EBP question 







Level IV  
N=45  




MEOWS enabled communication 
about vital signs 
Trigger prompts helped shape shared 
understandings of maternal 
complications.  
Conflicting results of the effectiveness 
of early warning systems exists; value 
in MEOWS in structuring the 
surveillance of hospitalized women 
with an established risk of morbidity 
has to be weighed with opportunity 
costs of MEWOS and variation in 
implementation  
  Semi-structured 
interviews and 
documentation review 
performed in the 
maternity services 
AIM-to explore 
implementation of the 
MEOWS in practice to further 
understand the influence of 
contextual factors 





 MEWC is triggers a prompt bedside 
alert with 1 abnormal parameter. 
Single scoring system 
Benefits: minimize false alarms, 
facilitate implementation, retain 
sensitivity 
MEWC is required for use in all New 
York hospitals with obstetric services 
 Used a consensus-based 
approach to define 
MEWC, a list of 
abnormal parameters 
that include the need for 
urgent bedside 
evaluation by a 
clinician.  
Authors urge randomized 
control trials to evaluate 
whether the MEWC help 
teams achieve timely 
diagnosis and treatment thus 
limiting severity of morbidity. 
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5 EPIC EHR 
facilities 
Obstetric Vital Sign Alert (OBVSA) uses 6 
critical values which are assessed and 
scored per established ranges, 2 deviations 
above or below normal ranges.  
Variables are updated in real-time in EPIC 
and display on electronic dashboard 
Aggregate scores are automatically 
calculated based on documentation, then 
display as a visual on a dashboard 
• Normal = < 2  
• Modest Deviation = 3-4 
• Severe Deviation = > 5 
 
Protocols guide nursing documentation 
and interventions 
Nurses discuss score at each handoff 
Actual sample 
could be affected 
by factors not 
controlled for: 
experience level 
of nurses, volume 
and acuity of 
patients in labor 
and delivery and 
mother baby 
units, attention to 
the new tool, 
attendance at the 
learning module, 
and buy-in and 
compliance of the 
nursing and 
physician groups. 
Scoring as there 
is limited pulse 
oximetry on the 
mother baby unit. 
OBVSA- aggregate 
weighted electronic 
scoring system that is 
embedded into the 
EPIC HER.  
Dependent variables 
before and after 
implementing OBVSA:  
• Response time 
• Time to intervention 
• Total estimated blood 
loss 
• PRBA units 
transfused 
• Maximum pulse 
• Lowest hemoglobin 
• Lowest sBP 
• Lowest dBP 
• Length of stay 
Built on work of MEOWS 
by seeking to automate the 
scoring and trigger tools, 
and optimize the use of the 
HER and the team response 
to changing patient 
conditions.  
Measurements pertained to 
obstetrical hemorrhage but 
principles can be applied to 

















Participants responded fastest and made 
the fewest errors when using the chart 
design without individual vital-sign 
scoring-rows.  
Participants were faster when the rows for 
scoring individual vital signs were 
separated (vs. grouped), but accuracy did 
not differ.  
Significantly more time-points were 
affected by scoring errors compared with 
adding errors. Early-warning scoring 
systems may be more effective without 
individual vital sign-scoring rows.  
 Within subjects, with 
“scoring-system 
design” as independent 
variable and 
participants’ response 
times and error rates as 
the main outcome 
measures. 
Participants response 
times and error rates for 
determining the overall 
scores were measured 
for 54 time-points per 
design. 
AIM-to evaluate the effect 
of early-warning scoring 
system design on speed and 
accuracy of scoring.  
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Sepsis patients  








Modified Obstetric Early Warning Scoring 
Systems (MOEWS) were searched from 
global literature and scores were derived 
for each set of vital sign recordings during 
presentation of chorioamnionitis. 
Six MOEWS evaluated: 
• Ability to predict severe deterioration= 
40-100% 
• Specificity varied from 4-97% 
• Positive predictive value from 2-15% 
Result-MOEWS with simple designs 
tended to be more sensitive, where as the 
more complex MOEWS were more 
specific but failed to identify some of the 
patients who developed severe sepsis. 
The study only 
focus on the use 
of MOEWS with 
the sepsis 
morbidity 
Hospital databases and 
patient records  
AIM-to compare predictive 
power of MOWES for the 
development of severe 
sepsis in women with 
chorioamnionitis 
Six MOEWS were 
identified for use in 
maternity care each with 
different physiological 
thresholds, clinical triggers, 
and ability to predict severe 
worsening of obstetric 
sepsis. 
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 EWS-other specialties-goal is to 
identify patients who may become 
critically ill and intervene early to 
improve outcomes. Method is a  
“trigger” or “scoring” system where a 
parameter or value is placed on the 
patient’s condition. Commonly used in 
pediatrics, general medical surgical 
wards. Systematic review shows 
overall impact on health outcomes and 
resource utilization is unclear. Major 
concern-various scoring systems and 
lack of consistency in detecting 
deterioration. Take home-Optimizing 
alert system performance to avoid 
false-positive results and avoid 
nuisance alarms.  
Maternal EWS-specifically designed to 
incorporate physiologic changes that 
occur during pregnancy and the small 
number of conditions responsible for 
most maternal severe morbidity and 
mortality. The United Kingdom’s 
MEOWS alert parameters may detect 
hemorrhage, sepsis, preeclampsia, and 
cardiovascular complications. 
Simplified version from United States 
offered as MEWC where 1 trigger 
prompts bedside assessment.  
Supporting Evidence-Singh et al., 
Carle et al., Austin et al, 
  AIM: Review the following 
strategies that improve 
maternal outcomes: 
• Clinical rationale for EWS 
including research literature 
in on early alerts in other 
specialties 
• Clinical parameters and 
recommended care in 
maternal EWS 
• Research evidence 
supporting maternal EWS 
• Future directions in 
optimizing and validating 
maternal EWS 
 
Maternal early warning 
systems are favorable for 
reducing severe maternal 
morbidity and mortality if they 
identify patients at risk for 
critical illness and not result in 











Sample Size, & 
Setting 
Study findings that help 
answer the EBP question 
Limitations Measurement Other notes 






2 acute care general 
hospitals’ mortality 
rates for 3 main 
specialties each 
 
During electronic physiological 
surveillance system (EPSS), crude 
mortality fell 
• Hospital #1: 7.75% to 6.42% 
• Hospital #2: 7.5% to 6.15% 
Both hospitals had abrupt and 
sustained mortality reductions during 
EPSS implementation 
The use of technology specifically 
designed to improve accuracy, 
reliability and availability of patients’ 
vital signs and early warning scores is 
associated with reduced mortality in 
this study.  





mortality rates.  
Study of seasonally 
adjusted in-hospital 
mortality rates before, 
during and after the 
sequential deployment 
and ongoing use of a 
hospital-wide EPSS  
EPSS uses wireless 
handheld computing 
devices, replaced a 
paper-based vital sign 
charting and clinical 
escalation system.  
AIM-to determine whether 
introducing an EPSS 
specifically designed to 
improve the collection and 
clinical use of vital sign data, 
reduced hospital mortality.  







50 Obstetric patients 
admitted to ICU; 50 
normal birth 
outcomes 
 7 pilot US hospitals 
 
Persistent MEWT were present in most 
obstetric ICU cases; their use might 
reduce maternal morbidity. 
Case and control groups each 
contained 50 patients with pre-
eclampsia (6/50, 12%) reason for 
admission to ICU.  
Significant associations Mean arterial 
pressure less than 65mm Hg (OR 4.5, 
95% CI 1.9-10.8)  
Used Mean 
Arterial Pressure 
(MAP) instead of 
blood pressures  
Small sample 
size; Lack of 
prospective data 
analysis 
6 MEWTs were 
assessed:  
HR, MAP, T, Mental 
State, RR, and Oxygen 
Level 
Odds ratio and 95% CI 
were generated for each 
of the 6 MEWTs, 
P<0.05 was considered 
significant  
MEWT in this cohort seemed 
to separate normal obstetric 
pts from those whom ICU 
admission was indicated  
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6 out of 29 hospitals in 
large hospital system  
24-month baseline 
control period at pilot 
and non-pilot facilities 
13-month MEWT 
study period at pilot 
and non-pilot facilities 
36,832 deliveries at 
pilot sites during 
baseline and MEWT 
study periods 
146, 359 deliveries at 
non-pilot sites during 
baseline and MEWT 
study periods 
Pilot site, screened patients-sensitivity 
for ICU admission was 96.9%, 
predictive positive value of 12%, and 
negative predictive value of 99.99% 
Significant reduction in both the 
Centers for Disease Control and 
Prevention defined severe maternal 
morbidity (-18.4%, P = .01) and 
composite maternal morbidity (-
13.6%, P = .01) when comparing 
baseline and after implementation of 
the MEWT tool.  
Use of the MEWT tool resulted in 
significant reductions in CDC severe 
maternal morbidity (P < 0.01) and 
composite morbidity (P < 0.01). 
Use of the MEWT, designed to address 
4 common causes of maternal 
morbidity, as well as, provide 
assessment and management 
recommendations, resulted in 
significant improvement in maternal 
morbidity.  
 

















The reduction in 
severe maternal 
morbidity noted 
at pilot sites may 
have been greater 
if the pilot sites 




in place.  
To determine if 
maternal morbidity 
might be reduced with 
the utilization of a 
MEWT 






To be considered 
positive, triggers 
needed to be sustained 
for >20 minutes and 
were defined as severe 
(single abnormal value). 
Obstacles to address with 
development of early warning 
systems: ease of use by staff, 
the alert frequency must be low 
enough to prevent “alarm 
fatigue” and the positive 
predictive value must be high 
enough clinicians value the 
alert.  
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Labor wards of a 
single hospital in India  
N=1065 study subjects 
Maternity Early Obstetric Warning 
System (MEOWS) “track and trigger” 
of physiological parameters can aid in 
recognition of maternal morbidity at an 
early stage, ultimately halting clinical 
deterioration and suffering maternal 
morbidity and mortality  
26.6% triggered an abnormal 
parameter 
16.61% fulfilled criterial for obstetric 
morbidity 
MEOWS chart was 86.4% sensitive, 
85.2% specificity, 53.8% positive 
predictability, 96.9% negative 
predictability. Parameters also had a 
significant correlation (p<0.05) with 
obstetric morbidity.   
Single study site MEOWS chart adopted 
from CEMACH 2003-
2005 
MEOWS is based on principle 
that abnormalities in the 
physiological parameters 
precede critical illness.  
AIM-to evaluate MEOWS 
chart as a bedside screening 
tool for predicting obstetric 
morbidity and to correlate 
each physiological parameter 
individually with obstetric 
morbidity 
Findings: MEOWS chart is 
useful tool at bedside for 
predicting maternal morbidity 
and mortality and should be 
used in every obstetric unit. 
Strict monitoring and 
documentation of 
physiological parameters 
should be a part of a patient’s 
assessment to pick up acute 
illness 
The hierarchy of levels of evidence follow recommendations from Melnyk and Fineout-Overholt (2015).   
BP-Blood Pressure 
CI-Confidence Interval 
HER-Electronic Health Record 
EWS-Early Warning System  
HR-Heart Rate 
ICU-Intensive Care Unit 
MAP-Mean Arterial Pressure  
MEOWS-Maternal Early Obstetric Warning System  
MEWC-Maternal Early Warning Criteria 
MEWT-Maternal Early Warning Triggers 
RR-Respiratory Rate 
T-Temperature 




IOWA Model of Evidence Based Practice  
(Titler et al., 2001) 
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Appendix I 
Cerner FetaLinkTM Web-Based Training Module   
                                    (Cerner FetaLinkTM, 2016) 
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(Cerner FetaLinkTM, 2016) 
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Appendix J 
Cerner FetaLinkTM Blood Pressure Alarm Notification  
(Cerner FetaLinkTM, 2016) 
 




(Cerner FetaLinkTM, 2016) 
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Appendix K 
Treatment Outcomes for Severe Range Blood Pressures  
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Appendix L 
DNP Essential Competency and Demonstration Method 
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